HIV Resource Materials for Physicians
Compiled by MATEC Michigan
November 28, 2011
Table of Contents
Section 1 Pathogenesis
A) HIV Overview: Pathogenesis and Natural History of HIV/AIDS
(Jon Cohn, MD, September 2006) (Click Here)
Section 2 Antiretroviral Treatment
A) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (US Department of Health and Human Services, November, 2011) (Click Here)
What to Start: Initial Combination of Regimens for the Antiretroviral –Naïve Patient (October 2011)(Click Here)
What’s new in the Guidelines (October 2011)(Click Here)
B) Antiretroviral Treatment of Adult HIV Infection: Recommendations of the IAS-USA Panel
(July 2010) (Click Here)
C) Supplementary Online Content: Antiretroviral Treatment of Adult HIV Infection: Recommendations of the IAS-USA Panel. JAMA. (July 2010) (Click Here)
D) Dosage Form Modifications and Renal/Hepatic Dosing of Antiretrovirals (National HIV/AIDS Clinicians’ Consultation Center, March 2009) (Click Here)
E) Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission , September 2011) (Click Here)
F) Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy (November 2, 2007) (Click Here)
G) Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (US Department of Health and Human Services, August 2011) (Click Here)
Section 3 Adherence
A) Adherence to Potent Antiretroviral Therapy (October 2004) (Click Here)
B) Promoting Adherence to Antiretroviral Therapy (AIDS Institute,
New York State, Department of Health) (Click Here)
C) Model of Adherence Workshop (J. Fisher, Ph.D, June 2000) (Click Here)
Section 4 Drug Resistance
A) Update of the Drug Resistance Mutations in HIV-1: December 2008 (International AIDS Society – USA, Topics in HIV Medicine, December 2009) (Click Here)
B) Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel (Click Here)
Section 5 HIV Patient Care
A) Primary Care Guidelines for the Management of Persons infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2009) (Click Here)
B) Initial Work-Up of HIV Infected Adult (Jon Cohn, MD, December 2009)
Recommended Health Maintenance (Jon Cohn, MD, December 2009) (Click Here)
C) Michigan AIDS Drug Assistance Program formulary (December 1, 2010) (Click Here)
D) Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations f the HIV Medicine Association of the Infectious Diseases Society of America (2005) (Click Here)
E) Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)–Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group (2003) (Click Here)
F) Cholesterol guidelines at a glance (National Cholesterol Education Program ATP III, 2004)
G) Retention in HIV care: A Guide to Patient-Centered Strategies (Click Here)
Section 6 Opportunistic Infections
A) Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (Recommendations of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association of the Infectious Diseases Society of America (HIVMA/IDSA); April 10, 2009) (Click Here)
B) Guidelines for Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children (Recommendations of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association of the Infectious Diseases Society of America (HIVMA/IDSA), the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics; September, 2009) (Click Here)
Section 7 HIV Prevention
A) Incorporating HIV Prevention into the Medical Care of Persons Living with HIV (CDC, HRSA, NIH and IDSA, July 2003) (Click Here)
B) Updated US Public Service Health Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Post Exposure Prophylaxis (Recommendations of the US Department of Health and Human Services, September 2005) (Click Here)
C) Antiretroviral Post Exposure Prophylaxis, After Sexual Injecting Drug Use, or other Non-Occupational Exposure to HIV in the United States (Recommendations of the US Department of Health and Human Services, January 2005) (Click Here)
D) Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV infection in Men Who Have Sex with Men (U.S Department of Health and Human Services, Center for Disease Control and Prevention, January 2011) (Click Here)
Section 8 STD Guidelines
A) Sexually Transmitted Diseases Treatment Guidelines (Department of
Health and Human Services Center for Disease Control and Prevention, 2010) (Click Here)
Section 9 Tuberculosis
A) Treatment of Tuberculosis (American Thoracic Society, CDC and IDSA, June 2003) (Click Here)
B) Managing Drug Interactions in the Treatment of HIV-related Tuberculosis (CDC, December 2007) (Click Here)
Section 10 Hepatitis
A) Chronic Hepatitis B (AASLD Practice Guidelines, September 2009) (Click Here)
B) Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel (2008) (Click Here)
C) Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the
HCV–HIV International Panel (Click Here)
D) Diagnosis, Management, and Treatment of Hepatitis C: An Update
(AASLD Practice Guidelines, October 2011) (Click Here)
E) Care of patients coinfected with HIV and hepatitis C virus: 2011 updated recommendations from the
US Department of Health and Human Services (June 2011) (Click Here)
Section 11 HIV Testing
A) Michigan HIV Laws for Health Care Providers (MDCH January 2006) (Click Here)
B) Position Statement: HIV Screening in Health Care Settings (MDCH, March 2007) (Click Here)
C) Questions and Answers about HIV Screening in Health Care Settings (Division of Health Wellness & Disease Control, MDCH; March 2007) (Click Here)
D) CDC Screening Guidelines Comparison to Michigan (Click Here)
E) Routine Testing: Sample Consent to Treatment Form (Click Here)
F) Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings (The Centers for Disease Control and Prevention (CDC), September 22, 2006)
Section 12 HIV Clinical Manual
A) Clinical Manual for the Management of the HIV Infected Adult (AIDS Education and Training Centers, 2006) (Click Here)
Section 13 HIV Resources
A) List of On-line HIV Resources (Click Here)
B) List of National Resources (Click Here)